STEM -- StemCells, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : STEM -- StemCells, Inc.

STEM 17.01

-2.0%

Jan 28 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: redbird who wrote (426)	3/14/2000 11:49:00 AM
From: tyoon	Read Replies (1) of 805

I went to the Institute for Genetic Medicine 4th Annual Symposium where Irving Weissman talked. He presented data that will be published in the April issue of Nature. it's pretty good! and why else would it be published in nature anyway. His stem cell transplantation for cancer therapy looks very good. He used sublethal doses of chemotherapy which will ablate blood cells also and kill the patient. He used mice to show that this could be counteracted by blood stem cell transplantation during chemotherapy. This showed regression of tumor while keeping the animals alive. He also has an assay developed to separate the bone marrow free from tumor metastasis. New England Journal of Medicine and the New York Times have reported the failure of stem cell transplantation but according to Irving Weissman, they didn't do it right! They did not eliminate tumor cells from metastasis. Also, they used "peripheral blood stem cells." Of course it's not going to work! just loaded up on CTII. Check out systemics (?) he also found that company too. tyoon

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next